MassDevice.com +5 | The top 5 medtech stories for June 22, 2017

Say hello to MassDevice +5, a bite-sized view of the top five medtech stories of the day. This feature of MassDevice.com’s coverage highlights our 5 biggest and most influential stories from the day’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry. Get this in your inbox everyday by subscribing to our newsletters.   5. pSivida seeks European regulatory nod for Durasert pSivida is looking to market its Durasert 3-year treatment for posterior segment uveitis in the European Union. Today, the Watertown, Mass.-based company submitted a marketing authorization application to the European Medicines Agency. Earlier this month, pSivida reported that its 2nd Phase III trial, which followed patients for 3 years, met its primary endpoint of prevention of recurrence of posterior uveitis at 6 months. Read more 4. Senate hews to House blueprint with new Trumpcare bill A new U.S. Senate version of the Trumpcare bill largely hews to the structure of the healthcare reform bill that passed the House last month, reportedly handing a huge tax cut to the rich by slashing the government’s contribution to the Medicaid program for the poor. The Senate bill would create a new tax credit for health insurance purchases and would allow states to drop Obamacare benefits such as maternity care, emergency services and mental health treatment, the New York Times reported. Although the Senate version would offer more ...
Source: Mass Device - Category: Medical Devices Authors: Tags: News Well Plus 5 Source Type: news